85 completed, 6 terminated, 2 recruiting, 2 withdrawn. 37 Phase 3, 30 Phase 4, 10 Phase 2, 8 Not applicable, 8 Phase 1.
Follow Risedronic Acid: new trials by email Literature Review of Risedronic Acid trials Research Report on Risedronic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy Camrelizumab + Risedronate Sodium + Chemotherapy - Breast Cancer Triple Negative Breast Cancer | Phase 2 | Active not recruiting | Harbin Medical University | 30 | 2026-03-04 | 2026-03-13 |
| Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis Alendronate, Ibandronate; Risedronate, Teriparatide - Osteoporosis, Osteoporosis, Postmenopausal | Not applicable | Completed | Khyber Medical University Peshawar | 40 | 2025-10-01 | 2026-08-13 |
| Rise & Renew: Supporting Well-Being in Black Women After the Loss of a Loved One Rise & Renew Hybrid Grief Support Program - Bereavement, Grief | Not applicable | Completed | Lillian Haley, PhD | 30 | 2025-05-20 | 2026-07-02 |
| Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery Risedronate, Placebo - Bone Loss | Phase 3 | Recruiting | Wake Forest University Health Sciences | 200 | 2023-03-28 | 2026-02-19 |
| Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women Risedronate Sodium 35 MG [Actonel], Calcium Vitamin D combination - Postmenopausal Osteoporosis | Phase 4 | Completed | Dong-A ST Co., Ltd. | 149 | 2023-01-03 | 2025-08-24 |
| Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients Risedronate, Vitamin D - Postmenopausal Osteoporosis, Hypovitaminosis D | Not applicable | Completed | Hospital Regional 1o de Octubre | 33 | 2021-07-01 | 2022-04-26 |
| Replication of the VERO Osteoporosis Trial in Healthcare Claims Data Teriparatide, Risedronate - Osteoporosis | Completed | Brigham and Women's Hospital | 12757 | 2020-10-29 | 2023-07-27 | |
| Effects of Bisphosphonates on OI-Related Hearing Loss Risedronate Oral Tablet - Osteogenesis Imperfecta | Phase 4 | Recruiting | Hospital for Special Surgery, New York | 100 | 2019-11-02 | 2026-04-28 |
| Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT risedronate, Matching placebo - Lung Neoplasm | Phase 2 | Completed | Wake Forest University Health Sciences | 84 | 2019-07-12 | 2026-08-03 |
| Weight Loss With Risedronate for Bone Health Risedronate Sodium 150 MG, Placebo - Bariatric Surgery Candidate, Bone Loss | Phase 4 | Completed | Wake Forest University Health Sciences | 24 | 2018-06-15 | 2021-02-09 |
| Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta? Risedronate Sodium, Calcichew tablets - Osteogenesis Imperfecta | Phase 2 | Completed | Sheffield Children's NHS Foundation Trust | 13 | 2017-04-01 | 2018-09-07 |
| Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis risedronate, placebo - Prosthesis Loosening | Phase 3 | Terminated | University Hospital, Limoges | 3 | 2016-05-01 | 2018-10-17 |
| Exome Sequencing for Atypical Femoral Fractures Bisphosphonate - Atypical Femoral Fractures, Osteoporosis | Completed | Washington University School of Medicine | 38 | 2016-04-01 | 2018-12-31 | |
| Heartland Osteoporosis Prevention Study Calcium Carbonate, Vitamin D3, Risedronate - Osteopenia | Phase 3 | Completed | University of Nebraska | 276 | 2015-02-01 | 2023-10-05 |
| Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty Risedronate - Osteoporotic Fractures, Femoral Neck Fracture | Phase 4 | Unknown | Mahidol University | 86 | 2013-06-01 | 2016-09-14 |
| Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey) Sodium Risedronate - Osteoporosis | Completed | Takeda | 3304 | 2013-05-27 | 2018-10-19 | |
| 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets Sodium risedronate - Osteoporosis | Completed | Takeda | 579 | 2013-05-13 | 2019-07-30 | |
| To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women Risedronate/Cholecalciferol combination(montly), Risedronate/Cholecalciferol combination(weekly) - Osteoporosis | Phase 4 | Completed | Hanlim Pharm. Co., Ltd. | 196 | 2012-12-01 | 2018-08-29 |
| VERtebral Fracture Treatment Comparisons in Osteoporotic Women Teriparatide, Risedronate, Placebo - Postmenopausal Osteoporosis | Phase 4 | Completed | Eli Lilly and Company | 1366 | 2012-10-01 | 2019-09-23 |
| Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids Denosumab, Placebo for risendronate, Risendronate - Steroid-induced Osteopor, Glucocorticoid-induced Ostepor | Phase 3 | Completed | Amgen | 795 | 2012-03-28 | 2018-07-27 |
Showing 20 of 97. Sign in to see all of them.
Osteoporosis (44) · Osteoporosis, Postmenopausal (23) · Bone Diseases, Metabolic (19) · Breast Neoplasms (6) · Prostatic Neoplasms (4) · Osteitis Deformans (3) · Osteogenesis Imperfecta (3) · Anorexia Nervosa (2) · Bone Resorption (2) · Hip Fractures (2) · Spinal Cord Injuries (2) · Spinal Fractures (2) · Adenocarcinoma (1) · Back Pain (1) · Breast Carcinoma In Situ (1)
Warner Chilcott (17) · Sanofi (15) · Eli Lilly and Company (4) · Takeda (4) · Hanlim Pharm. Co., Ltd. (3) · Wake Forest University Health Sciences (3) · Alliance for Clinical Trials in Oncology (2) · Amgen (2) · Massachusetts General Hospital (2) · Novartis Pharmaceuticals (2) · Organon and Co (2) · Toronto Rehabilitation Institute (2) · University of Alberta (2) · University of Nebraska (2) · AstraZeneca (1)
United States (51) · Canada (24) · France (16) · Spain (13) · Australia (11) · Belgium (11) · Poland (10) · United Kingdom (10) · Germany (9) · Argentina (8) · Italy (7) · Netherlands (7) · Czechia (6) · Hungary (6) · South Korea (6)
B. Cathy Craven, MD, FRCPC (2) · Chantell Wilson, PhD (2) · Dietrich H Wenderoth, MD (2) · Hyoung-Moo Park, MD (2) · Aasis Unnanuntana, MD (1) · Alec Walker, MD, DrPH (1) · Amy Sun, MD, PhD (1) · Ana Balske, MD, PhD (1) · Ana M Balske, MD (1) · Ana M Balske, MD, PhD (1) · Angela Rogers, Dr (1) · Anne Klibanski, M.D. (1)
PMID 38979716, PMID 16557117, PMID 16999712, PMID 17244788, PMID 17592924, PMID 18035193, PMID 18427147, PMID 18682511, PMID 19075260, PMID 19468757, PMID 21947137, PMID 22750403, PMID 22797188, PMID 23099796, PMID 23149277, PMID 23322362, PMID 23927913, PMID 24126237, PMID 24636210, PMID 25271941, PMID 26245807, PMID 26572609, PMID 27576310, PMID 28283937, PMID 29129436, PMID 29329484, PMID 30659410, PMID 30816640, PMID 31776637, PMID 32157334, PMID 32474650, PMID 33103032, PMID 33270906, PMID 34519832, PMID 36625789
1UL1RR025758 (1), 2005 (1), P30CA012197 (1), P50AT000477 (1), R01DK052625 (1), R01NR007743 (1), U01AR080969 (1)